Goldman Sachs Reiterates Neutral on Amarin Ahead of Advisory Panel
October 09, 2013 at 11:26 AM EDT
In a report published Wednesday, Goldman Sachs analyst Gary Nachman reiterated a Neutral rating and $6.80 price target on Amarin Corporation plc (NASDAQ: AMRN ). In the report, Goldman Sachs noted, “Given that the upcoming advisory panel for AMRN's Vascepa in the expanded ANCHOR indication on Oct. 16 is such
